Stay updated on Sitravatinib for Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Sitravatinib for Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sitravatinib for Metastatic Breast Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.5 to v3.6.6. This reflects a new version of the study record and associated documents, without altering the trial details.
    Difference
    0.1%
    Check dated 2026-08-29T20:08:35.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    Revision: v3.6.5 is now shown on the page, replacing v3.6.4. This reflects a new version of the page; no study content or user-facing features are changed.
    Difference
    0.1%
    Check dated 2026-08-08T17:59:19.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Revision label on the page updated from v3.6.3 to v3.6.4. This represents a minor backend/software update rather than a change to the study content or user-facing information.
    Difference
    0.1%
    Check dated 2026-07-25T09:26:14.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The page now shows revision v3.6.3, replacing the previous v3.6.2. This indicates a minor site update rather than changes to the study details.
    Difference
    0.1%
    Check dated 2026-07-03T21:46:47.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.2 to reflect an internal update to the page template or backend.
    Difference
    0.1%
    Check dated 2026-06-26T23:52:16.000Z thumbnail image
  9. Check
    86 days ago
    Change Detected
    Summary
    The page now states that recruitment is closed for the study, clarifying the participation status. It also adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and includes minor label updates and a revision note.
    Difference
    0.6%
    Check dated 2026-06-12T14:46:59.000Z thumbnail image

Stay in the know with updates to Sitravatinib for Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sitravatinib for Metastatic Breast Cancer Clinical Trial page.